Combined use of prospective antiretroviral pharmacokinetic profiling and HIV-1 genotypic resistance testing in managing antiretroviral therapy

被引:0
|
作者
Urban, A
Bean, P
Beckwith, M
Bellehumeur, J
Graziano, F
Aziz, D
机构
[1] Univ Wisconsin, Madison, WI 53706 USA
[2] Millennium Strategies, Madison, WI USA
[3] Specialty Labs, Santa Monica, CA USA
关键词
D O I
10.1016/S0091-6749(00)90960-6
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
532
引用
收藏
页码:S176 / S176
页数:1
相关论文
共 50 条
  • [1] HIV-1 genetic subtypes and antiretroviral therapy resistance testing
    Galpin, S
    Beddows, S
    Johargy, A
    Ashraf, A
    Prater, AJ
    White, N
    Clarke, J
    McClure, M
    Weber, JN
    [J]. AIDS, 2000, 14 : S118 - S118
  • [2] Implementing HIV-1 Genotypic Resistance Testing in Antiretroviral Therapy Programs in Africa: Needs, Opportunities, and Challenges
    Lessells, Richard J.
    Avalos, Ave
    de Oliveira, Tulio
    [J]. AIDS REVIEWS, 2013, 15 (04) : 221 - 229
  • [3] Phylogenetic internal control for HIV-1 genotypic antiretroviral testing
    Boeri, E
    Canducci, E
    Grasso, MA
    Presi, S
    Carrera, P
    Racca, S
    Clementi, M
    [J]. MICROBIOLOGICA, 2004, 27 (02): : 105 - 109
  • [4] HIV-1 genotypic resistance profile of patients failing antiretroviral therapy in Parana Brazil
    Michelon Toledo, Paula Virginia
    de Carvalho, Denise Siqueira
    Romagnoli, Luiza
    Marcinko, Gustavo
    da Cunha, Clovis Arns
    de Souza, Margely Nunes
    Brindeiro, Rodrigo
    de Queiroz-Telles, Flavio
    [J]. BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2010, 14 (04): : 360 - 371
  • [5] Quality control assessment for HIV-1 genotypic antiretroviral testing (2002)
    Brun-Vézinet, F
    Masquelier, B
    Izopet, J
    Calvez, V
    Chaix, ML
    Ruffault, A
    Tamalet, C
    Yerly, S
    Descamps, D
    Costagliola, D
    [J]. ANTIVIRAL THERAPY, 2003, 8 (03) : U91 - U91
  • [6] Genotypic HIV-1 drug resistance testing in antiretroviral-naive subjects in Houston, Texas
    Nannini, EC
    Han, XL
    O'Brien, WA
    Arduino, RC
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 29 (03) : 317 - 319
  • [7] Pharmacokinetic monitoring of HIV-1 protease inhibitors in the antiretroviral therapy
    Pawinski, Tomasz
    Pulik, Piotr
    Gralak, Beata
    Horban, Andrzej
    [J]. ACTA POLONIAE PHARMACEUTICA, 2008, 65 (01): : 93 - 100
  • [8] Use of genotypic assays for the detection of HIV antiretroviral resistance
    Nicastri, E
    Ippolito, G
    [J]. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2003, 35 : 24 - 28
  • [9] HIV-1 genotypic profiling ensures effective response to third-line antiretroviral therapy in Cameroon
    Mbouyap, Pretty Rosereine
    Fokam, Joseph
    Semengue, Ezechiel Ngoufack Jagni
    Mossiang, Leonella
    Takou, Desire
    Chenwi, Collins Ambe
    Nka, Alex Durand
    Dambaya, Beatrice
    Teto, Georges
    Beloumou, Grace Angong
    Ndjeyep, Sandrine Claire Djupsa
    Ka'e, Aude Christelle
    Kouanfack, Charles
    Ndjolo, Alexis
    Keou, Francois-Xavier Mbopi
    [J]. MEDICINE, 2023, 102 (22) : E33897
  • [10] Cost effectiveness analysis of routine use of genotypic antiretroviral resistance testing after failure of antiretroviral treatment for HIV
    Corzillius, M
    Mühlberger, N
    Sroczynski, G
    Jaeger, H
    Wasem, J
    Siebert, U
    [J]. ANTIVIRAL THERAPY, 2004, 9 (01) : 27 - 36